Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 4 1

Status

Completed 3Recruiting 2

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3Endocrine 2NET 1

Conditions

Gastric Cancer After D2 Lymph Node Dissection 1Gallbladder Neoplasms 1Carcinoma, Hepatocellular 1

Interventions

Fluorouracil 616Oxaliplatin 579Gemcitabine 492Capecitabine 445Leucovorin 427Irinotecan 390Bevacizumab 330Cisplatin 320Radiotherapy 245Cetuximab 215Sorafenib 167pembrolizumab 152Docetaxel 150Paclitaxel 140Nivolumab 128Albumin-Bound Paclitaxel 108130-nm albumin-bound paclitaxel 108Folfox protocol 101Panitumumab 95Erlotinib Hydrochloride 95Surgical Procedures, Operative 86regorafenib 84S 1 (combination) 81Drug Therapy 80Radiation 69Carboplatin 65Neoadjuvant Therapy 64Colonoscopy 64Radiosurgery 63Surveys and Questionnaires 60

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Somatostatin × Gastrointestinal × Clear all
NCT01053390 2013-12-20

New Chemotherapy Regimen in the Treatment of Advanced Gallbladder Carcinoma

Shanghai Jiao Tong University School of Medicine

Phase 3 Completed
216 enrolled
Gastrointestinal

Gallbladder Neoplasms

NCT01914692 2013-08-02

Application of Somatostatin for Advanced Gastric Cancer After D2 Lymph Node Dissection

First Affiliated Hospital, Sun Yat-Sen University

Phase 4 Completed
2 enrolled
Gastrointestinal

Gastric Cancer After D2 Lymph Node Dissection

NCT00386984 2006-10-12

Hector-Study to Evaluate the Efficacy of Octreotide in Patients With Inoperable Hepatocellular Carcinoma

University Hospital Freiburg

Phase 3 Completed
108 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡